Cancer Family
Malignant Neoplasm
CI-CAN-00000025CAExplore in graph →
20,116 active trials259 approved drugs3,741 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000025CAExplore in graph →
Clinical trials
90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (11,163)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00067288 | Meaning-Centered Psychotherapy in Advanced Cancer | completed | Phase 2 | 118 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00070967 | Acupuncture to Improve Quality of Life in Patients With Advanced Cancer | completed | Phase 2 | 40 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 |
| clinicaltrials |
| NCT00082303 | Music Imagery for Patients Receiving Chemotherapy for Leukemia or Non-Hodgkin's Lymphoma | completed | Phase 1 / Phase 2 | 60 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00364715 | Study the Expression of Annexin A1 and Its Potential Usage as a Prognostic Marker in Oral Cancer | completed | — | — | National Taiwan University HospitalOTHER | 1 | Aug 17, 2006 | clinicaltrials |
| NCT00036543 | A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer | completed | Phase 3 | 1,000 | AbbottINDUSTRY | 18 | Aug 15, 2006 | clinicaltrials |
| NCT00102375 | Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer | completed | Phase 3 | 900 | AGO Study GroupOTHER | 1 | Aug 4, 2006 | clinicaltrials |
| NCT00191841 | Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 24, 2006 | clinicaltrials |
| NCT00034268 | A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer | completed | Phase 3 | — | Eli Lilly and CompanyINDUSTRY | 21 | Jul 19, 2006 | clinicaltrials |
| NCT00034463 | ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer | completed | Phase 1 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jul 19, 2006 | clinicaltrials |
| NCT00034502 | A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer. | completed | Phase 1 / Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 2 | Jul 19, 2006 | clinicaltrials |
| NCT00034606 | Comparing 3 Schedules of Alimta Plus Gemzar | completed | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jul 19, 2006 | clinicaltrials |
| NCT00034619 | A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer. | completed | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jul 19, 2006 | clinicaltrials |
| NCT00042679 | A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer. | completed | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jul 19, 2006 | clinicaltrials |
| NCT00051493 | ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial. | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 19, 2006 | clinicaltrials |
| NCT00097383 | Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 5 | Jul 19, 2006 | clinicaltrials |
| NCT00001533 | Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine | completed | Phase 1 | 25 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Jul 17, 2006 | clinicaltrials |
| NCT00001579 | A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors | completed | Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Jul 17, 2006 | clinicaltrials |
| NCT00352404 | Chromoscopic Guided Endomicroscpy to Diagnose Colitis Associated Dysplasia | completed | Phase 3 | 114 | Johannes Gutenberg University MainzOTHER | 1 | Jul 14, 2006 | clinicaltrials |
| NCT00054873 | Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer | completed | Phase 2 | — | Chiron CorporationINDUSTRY | 1 | Jul 11, 2006 | clinicaltrials |
| NCT00350597 | GM-CSF as Adjuvant Therapy of Melanoma | completed | Phase 2 | 50 | Northern California Melanoma CenterOTHER | 1 | Jul 11, 2006 | clinicaltrials |
| NCT00122720 | The Effect of Darbepoetin Upon Rehabilitation for Colorectal Cancer Surgery | completed | Phase 4 | 200 | Herning HospitalOTHER | 1 | Jul 7, 2006 | clinicaltrials |
| NCT00087997 | A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas | completed | Phase 2 | 80 | Synta Pharmaceuticals Corp.INDUSTRY | 2 | Jun 20, 2006 | clinicaltrials |
| NCT00096837 | A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma | completed | Phase 2 | 25 | Pharmacyclics LLC.INDUSTRY | 1 | Jun 8, 2006 | clinicaltrials |
| NCT00263107 | Postoperative Telerounding: A Multi-Center Prospective Randomized Assessment of Patient Outcomes and Satisfaction. | completed | — | 270 | University of California, DavisOTHER | 1 | May 31, 2006 | clinicaltrials |
| NCT00275353 | Effectiveness of an Individualized Symptom Education Program (ISEP) | completed | Phase 2 | 144 | University of TorontoOTHER | 1 | May 26, 2006 | clinicaltrials |
| NCT00044733 | Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell Transplant | completed | Phase 2 | 38 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | May 18, 2006 | clinicaltrials |
| NCT00325611 | Multidisciplinary Inpatient Palliative Care Intervention | completed | N/A | 550 | Kaiser PermanenteOTHER | 1 | May 15, 2006 | clinicaltrials |
| NCT00323505 | A Phase II Trial Comparing the Quality of Life, Tolerability and Toxicity of PEG Intron With INTRON® A in Patients With Multiple Myeloma | completed | Phase 2 | — | Royal Marsden NHS Foundation TrustOTHER | 1 | May 9, 2006 | clinicaltrials |
| NCT00291434 | Altered and Conventional Fractionated Radiotherapy in Patients With Head and Neck Cancer | completed | — | 152 | Institute of Radiotherapy and Oncology, MacedoniaOTHER | 0 | May 4, 2006 | clinicaltrials |
| NCT00209638 | Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer | completed | Phase 1 / Phase 2 | 24 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 0 | Apr 21, 2006 | clinicaltrials |
| NCT00312988 | Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy | completed | Phase 3 | 450 | North Eastern German Society of Gynaecological OncologyOTHER | 1 | Apr 11, 2006 | clinicaltrials |
| NCT00309530 | Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C | completed | Phase 3 | 598 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Apr 3, 2006 | clinicaltrials |
| NCT00309543 | Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B | completed | Phase 3 | 636 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Apr 3, 2006 | clinicaltrials |
| NCT00306969 | Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma | completed | Phase 1 / Phase 2 | 18 | Boston UniversityOTHER | 1 | Mar 27, 2006 | clinicaltrials |
| NCT00011518 | Bladder Cancer Case Control Study of Arsenic in Water | completed | — | 600 | National Institute of Environmental Health Sciences (NIEHS)NIH | 1 | Mar 23, 2006 | clinicaltrials |
| NCT00014963 | Biomarkers of Benzene Exposure in Inner City Residents | completed | — | 90 | National Institute of Environmental Health Sciences (NIEHS)NIH | 1 | Mar 23, 2006 | clinicaltrials |
| NCT00305149 | Risk Adapted Beacopp Regimen for Standard and High Risk Hodgkin Lymphoma | completed | N/A | 130 | Rambam Health Care CampusOTHER | 1 | Mar 21, 2006 | clinicaltrials |
| NCT00301548 | Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast Cancer | completed | Phase 2 | 172 | European Institute of OncologyOTHER | 0 | Mar 13, 2006 | clinicaltrials |
| NCT00301275 | Assessing Free Immunoglobulin Light Chains in Patients With Myeloma | completed | — | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Mar 10, 2006 | clinicaltrials |
| NCT00300521 | Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma | completed | Phase 2 | 40 | Beijing Chao Yang HospitalOTHER | 1 | Mar 9, 2006 | clinicaltrials |
| NCT00073502 | Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer | completed | Phase 2 | 43 | OSI PharmaceuticalsINDUSTRY | 3 | Feb 22, 2006 | clinicaltrials |
| NCT00291369 | Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate Prognosis | completed | Phase 3 | 456 | Centre Leon BerardOTHER | 1 | Feb 16, 2006 | clinicaltrials |
| NCT00054808 | Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma | completed | Phase 2 | 40 | Genta IncorporatedINDUSTRY | 1 | Feb 8, 2006 | clinicaltrials |
| NCT00045864 | Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma. | completed | Phase 2 | — | Chiron CorporationINDUSTRY | 1 | Feb 6, 2006 | clinicaltrials |
| NCT00045877 | Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments | completed | Phase 2 / Phase 3 | — | Chiron CorporationINDUSTRY | 1 | Feb 6, 2006 | clinicaltrials |
| NCT00035022 | Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas | completed | Phase 1 / Phase 2 | 71 | BioCryst PharmaceuticalsINDUSTRY | 1 | Jan 13, 2006 | clinicaltrials |
| NCT00273247 | Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis | completed | Phase 3 | 150 | National Cancer Institute, MilanOTHER | 1 | Jan 9, 2006 | clinicaltrials |
| NCT00144053 | A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer | completed | Phase 3 | 450 | West Japan Thoracic Oncology GroupOTHER | 0 | Jan 6, 2006 | clinicaltrials |
| NCT00148291 | Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 3 | 180 | West Japan Thoracic Oncology GroupOTHER | 0 | Jan 6, 2006 | clinicaltrials |
| NCT00219752 | Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years | completed | Phase 2 | 30 | Poitiers University HospitalOTHER | 1 | Dec 22, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Aug 18, 2006source: clinicaltrials